Furthermore, the role of glucagon has been investigated in the pathophysiology of metabolic disorders, where absence of glucagon action was shown to ameliorate diet-induced obesity and diabetes. This evidence concerns the gene GCG and obesity due to melanocortin 4 receptor deficiency.